PE20130283A1 - Cristal de compuesto de amida - Google Patents
Cristal de compuesto de amidaInfo
- Publication number
- PE20130283A1 PE20130283A1 PE2012002427A PE2012002427A PE20130283A1 PE 20130283 A1 PE20130283 A1 PE 20130283A1 PE 2012002427 A PE2012002427 A PE 2012002427A PE 2012002427 A PE2012002427 A PE 2012002427A PE 20130283 A1 PE20130283 A1 PE 20130283A1
- Authority
- PE
- Peru
- Prior art keywords
- amida
- compound crystal
- crystal
- methoxibutyl
- interplan
- Prior art date
Links
- 241000670727 Amida Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- HPNDNWLIWLJPII-UHFFFAOYSA-N 1h-benzimidazole-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2NC(C(=O)N)=NC2=C1 HPNDNWLIWLJPII-UHFFFAOYSA-N 0.000 abstract 1
- KTOQRRDVVIDEAA-UHFFFAOYSA-N 2-methylpropane Chemical class [CH2]C(C)C KTOQRRDVVIDEAA-UHFFFAOYSA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN CRISTAL DE CLORHIDRATO DE 1-(4-METOXIBUTIL)-N-(2-METILPROPIL)-N-[(3S,5R)-5-(MORFOLIN-4-ILCARBONIL)PIPERIDIN-3-IL]-1H-BENCIMIDAZOL-2-CARBOXAMIDA CON UN PATRON DE DIFRACCION DE RAYOS X DE POLVO CON CARACTERISTICAS PICO EN LOS ESPACIAMIENTOS INTERPLANOS (d) DE ALREDEDOR DE 26.43 ± 0.2, 7.62 ± 0.2, 4.32 ± 0.2, 3.08 ± 0.2, 2.59 ± 0.2 Y 2.33 ± 0.2 ANGSTROMS. DICHO CRISTAL ES INHIBIDOR DE RENINA SIENDO UTIL COMO AGENTE PROFILACTICO O TERAPEUTICO DE LA HIPERTENSION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010137194 | 2010-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20130283A1 true PE20130283A1 (es) | 2013-03-25 |
Family
ID=45348277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2012002427A PE20130283A1 (es) | 2010-06-16 | 2011-06-15 | Cristal de compuesto de amida |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US9018374B2 (es) |
| EP (1) | EP2583967B1 (es) |
| JP (1) | JP5782438B2 (es) |
| KR (1) | KR20130119903A (es) |
| CN (1) | CN103068816B (es) |
| AU (1) | AU2011266099B2 (es) |
| BR (1) | BR112012032055B8 (es) |
| CA (1) | CA2802483C (es) |
| CL (1) | CL2012003526A1 (es) |
| CO (1) | CO6670573A2 (es) |
| DO (1) | DOP2012000313A (es) |
| EA (1) | EA022094B1 (es) |
| EC (1) | ECSP13012392A (es) |
| ES (1) | ES2524896T3 (es) |
| GE (1) | GEP20146195B (es) |
| IL (1) | IL223562A (es) |
| MA (1) | MA34378B1 (es) |
| MX (1) | MX2012014828A (es) |
| MY (1) | MY163927A (es) |
| PE (1) | PE20130283A1 (es) |
| PH (1) | PH12012502468A1 (es) |
| SG (1) | SG186223A1 (es) |
| TN (1) | TN2012000589A1 (es) |
| TW (1) | TWI511967B (es) |
| UA (1) | UA108888C2 (es) |
| WO (1) | WO2011158880A1 (es) |
| ZA (1) | ZA201300065B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2800734A1 (en) * | 2012-02-14 | 2014-11-12 | Dow Global Technologies LLC | Nonionic surfactant compositions |
| WO2013122260A1 (en) | 2012-02-15 | 2013-08-22 | Takeda Pharmaceutical Company Limited | Tablet |
| CN103831159B (zh) * | 2014-01-20 | 2016-04-13 | 华润赛科药业有限责任公司 | 一种阿齐沙坦微粉化方法 |
| EP3130581A4 (en) * | 2014-04-10 | 2017-11-22 | Takeda Pharmaceutical Company Limited | Method for producing heterocyclic compound |
| GB2542876B (en) * | 2015-04-20 | 2019-10-23 | Johnson Matthey Plc | Structure Directing Agent |
| CN107595853A (zh) * | 2017-10-25 | 2018-01-19 | 桂林浩新科技服务有限公司 | 一种用于治疗高血压合并冠心病的药物组合物及其用途 |
| CN107595842A (zh) * | 2017-10-25 | 2018-01-19 | 桂林浩新科技服务有限公司 | 一种药物复方制剂及在制备治疗高血压合并冠心病的药物中的用途 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0862562B1 (en) | 1995-09-13 | 2001-07-04 | Takeda Chemical Industries, Ltd. | Benzoxazepine compounds, their production and use as lipid lowering agents |
| CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| EP1302462A4 (en) | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF |
| US7342117B2 (en) * | 2001-10-30 | 2008-03-11 | Astellas Pharma Inc. | α-form or β-form crystal of acetanilide derivative |
| AR041867A1 (es) | 2002-11-01 | 2005-06-01 | Takeda Pharmaceutical | Agente para prevenir o tratar neuropatia |
| US7960369B2 (en) | 2002-11-08 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
| CA2507026A1 (en) | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, their production and use |
| US20060223831A1 (en) | 2003-04-15 | 2006-10-05 | Isao Kinoyama | Bromide and its crystal |
| JP3618341B2 (ja) * | 2003-04-15 | 2005-02-09 | 山之内製薬株式会社 | 臭化物及びその結晶 |
| EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| JP2006527770A (ja) | 2003-06-18 | 2006-12-07 | アストラゼネカ アクチボラグ | Ｃｂ１モジュレーターとしての２−置換５，６−ジアリール−ピラジン誘導体 |
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| CA2550012A1 (en) | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same and use |
| TW200523247A (en) | 2003-12-25 | 2005-07-16 | Takeda Pharmaceutical | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| US7585880B2 (en) | 2003-12-26 | 2009-09-08 | Takeda Pharmaceutical Company Limited | Phenylpropanoic acid derivatives |
| US7786165B2 (en) | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| EP1731505B1 (en) | 2004-03-30 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| WO2006112549A1 (ja) | 2005-04-20 | 2006-10-26 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
| US20090208584A1 (en) | 2005-06-09 | 2009-08-20 | Tomohiro Yoshinari | Solid preparation |
| GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| EP1911738A4 (en) | 2005-07-29 | 2009-12-16 | Takeda Pharmaceutical | COMPOUND OF PHENOXYALKANOIC ACID |
| JP5084503B2 (ja) | 2005-07-29 | 2012-11-28 | 武田薬品工業株式会社 | シクロプロパンカルボン酸化合物 |
| EP1912645A2 (en) | 2005-08-10 | 2008-04-23 | Takeda Pharmaceutical Company Limited | Therapeutic agent for diabetes |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| PT2248812E (pt) | 2006-06-27 | 2014-03-12 | Takeda Pharmaceutical | Compostos cíclicos fundidos como moduladores do receptor gpr40 |
| WO2008047821A1 (en) | 2006-10-18 | 2008-04-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| WO2008050821A1 (en) | 2006-10-19 | 2008-05-02 | Takeda Pharmaceutical Company Limited | Indole compound |
| WO2008093639A1 (ja) | 2007-01-29 | 2008-08-07 | Takeda Pharmaceutical Company Limited | ピラゾール化合物 |
| AU2008215490A1 (en) | 2007-02-09 | 2008-08-21 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of PPAR-gamma |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| WO2008156757A1 (en) | 2007-06-19 | 2008-12-24 | Takeda Pharmaceutical Company Limited | Indazole compounds for activating glucokinase |
| JP2010229034A (ja) | 2007-07-26 | 2010-10-14 | Dainippon Sumitomo Pharma Co Ltd | 二環性ピロール誘導体 |
| EP2297114B1 (en) * | 2008-06-19 | 2018-06-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| JP4901849B2 (ja) | 2008-12-15 | 2012-03-21 | バブコック日立株式会社 | 空気清浄機、及び分析室、並びに空気の浄化方法 |
| US8642622B2 (en) | 2010-06-16 | 2014-02-04 | Bristol-Myers Squibb Company | Piperidinyl compound as a modulator of chemokine receptor activity |
-
2011
- 2011-06-15 MX MX2012014828A patent/MX2012014828A/es active IP Right Grant
- 2011-06-15 ES ES11795784.5T patent/ES2524896T3/es active Active
- 2011-06-15 MY MYPI2012005311A patent/MY163927A/en unknown
- 2011-06-15 WO PCT/JP2011/063735 patent/WO2011158880A1/ja not_active Ceased
- 2011-06-15 TW TW100120982A patent/TWI511967B/zh not_active IP Right Cessation
- 2011-06-15 CA CA2802483A patent/CA2802483C/en not_active Expired - Fee Related
- 2011-06-15 PH PH1/2012/502468A patent/PH12012502468A1/en unknown
- 2011-06-15 EA EA201291453A patent/EA022094B1/ru not_active IP Right Cessation
- 2011-06-15 EP EP11795784.5A patent/EP2583967B1/en active Active
- 2011-06-15 UA UAA201300523A patent/UA108888C2/ru unknown
- 2011-06-15 GE GEAP201112963A patent/GEP20146195B/en unknown
- 2011-06-15 PE PE2012002427A patent/PE20130283A1/es active IP Right Grant
- 2011-06-15 US US13/704,039 patent/US9018374B2/en not_active Expired - Fee Related
- 2011-06-15 KR KR1020137000759A patent/KR20130119903A/ko not_active Ceased
- 2011-06-15 JP JP2012520480A patent/JP5782438B2/ja not_active Expired - Fee Related
- 2011-06-15 CN CN201180039608.XA patent/CN103068816B/zh not_active Expired - Fee Related
- 2011-06-15 SG SG2012090122A patent/SG186223A1/en unknown
- 2011-06-15 AU AU2011266099A patent/AU2011266099B2/en not_active Ceased
- 2011-06-15 BR BR112012032055A patent/BR112012032055B8/pt not_active IP Right Cessation
- 2011-06-16 MA MA35560A patent/MA34378B1/fr unknown
-
2012
- 2012-12-11 IL IL223562A patent/IL223562A/en active IP Right Grant
- 2012-12-13 TN TNP2012000589A patent/TN2012000589A1/en unknown
- 2012-12-13 CL CL2012003526A patent/CL2012003526A1/es unknown
- 2012-12-14 DO DO2012000313A patent/DOP2012000313A/es unknown
-
2013
- 2013-01-03 ZA ZA2013/00065A patent/ZA201300065B/en unknown
- 2013-01-15 CO CO13006575A patent/CO6670573A2/es unknown
- 2013-01-16 EC ECSP13012392 patent/ECSP13012392A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20130283A1 (es) | Cristal de compuesto de amida | |
| MX346318B (es) | Cristales. | |
| PE20121179A1 (es) | Forma cristalina de hemifumarato de alisquireno | |
| EA201290655A1 (ru) | Новые производные замещенного бициклического триазола в качестве модуляторов гамма-секретазы | |
| PE20140011A1 (es) | Compuestos y composiciones novedosos para la inhibicion de nampt | |
| EA201690223A1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
| CL2012001328A1 (es) | Compuestos derivados de (4,5,6,7-tetrahidro-1h-indazol-3-il)-1h-indol, inhibidores de itk; composicion farmaceutica; utiles en el tratamiento de enfermedades inflamatorias, tales como artritis reumatoidea, alergias, enfermedades autoinmunes, entre otras. | |
| EA201290121A1 (ru) | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов | |
| CY1117085T1 (el) | C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης | |
| NZ621221A (en) | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof | |
| SG10201803874PA (en) | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor | |
| CL2013000308A1 (es) | Uso de compuestos heterociclicos con nitrogeno, oxigeno o azufre, para tratar una imperfeccion de la piel tal como una herida superficial, cicatriz o arruga; composiciones farmaceuticas. | |
| UA107967C2 (en) | Pharmaceutical composition in the form of bilayer tablets which contain inhibitor of hmg-coa reductase inhibitor and irbesartan | |
| MX361458B (es) | Compuestos de pirimido-piridazinona y uso de los mismos. | |
| PE20140123A1 (es) | Formas cristalinas de la sal clorhidrato de (4a-r,9a-s)-1-(1h-benzoimidazol-5-carbonil)-2,3,4,4a,9,9a-hexahidro-1h-inden[2,1-b]piridin-6-carbonitrilo y su uso como inhibidores de hsd 1 | |
| FR2968950B1 (fr) | Composition cosmetique comprenant un compose d'acide cucurbique | |
| EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 | |
| NZ582556A (en) | Pharmaceutical composition for treating wounds and related methods | |
| BR112012015084A2 (pt) | composição farmacêutica de liberação lenta de iloperidone | |
| EA201391524A1 (ru) | Производные гликозида и их применение | |
| TR201005325A2 (tr) | Atorvastatin ve aspirin içeren farmasötik formülasyonlar | |
| EA201170481A1 (ru) | Сокристаллы | |
| EA201290534A1 (ru) | Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов | |
| EA201070690A1 (ru) | Композиция для личного ухода | |
| ECSP23058279A (es) | Antagonistas de gitr y métodos de uso de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |